Research for biomarkers of serum/CSF in patients with rapidly progressive dementia including human prion disease

Research for biomarkers of serum/CSF in patients with rapidly progressive dementia including human prion disease - Research for biomarkers of serum/CSF in patients with rapidly progressive dementia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016855

Enrollment

1500

Registered

2015-04-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rapidly progressive dementia including human prion disease

Interventions

one year 500 cases three years 1500 cases 472 cases nominated from April 2015 to March 2016. And 492 cases nominated from April 2016 to March 2017.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The cases suspected rapidly progressive dementia including prion disease

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The sensitivity and specificity of biomarkers among the 1500 cases during three years	—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe

Contacts

Public ContactKatsuya Satoh

Nagasaki University Graduate School of Biomedical Sciences Department of Locomotive Rehabilitation Science, Unit of Rehabilitation Sciences

satoh-prion@nagasaki-u.ac.jp095-819-7991

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026